Addendum to Covid Vaccine Guidance Published Today

Health Canada and NACI recommend Updated Vaccine (Booster) GUIDANCE

Beginning in the fall of 2023 for those previously vaccinated against COVID-19, NACI recommends a dose of the XBB.1.5-containing formulation of COVID-19 vaccine for individuals in the authorized age group if it has been at least 6 months* from the previous COVID-19 vaccine dose or known SARS-CoV-2 infection (whichever is later).

Immunization is particularly important for those at increased risk of COVID-19 infection or severe disease, for example:

  • Adults 65 years of age or older;

  • Residents of long-term care homes and other congregate living settings;

  • Individuals with underlying medical conditions that place them at higher risk

    of severe COVID-19;

  • Individuals who are pregnant;

  • Individuals in or from First Nations, Métis and Inuit communities**;

  • Members of racialized and other equity-deserving communities;

  • People who provide essential community services.

Charlotte Gallant